These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35894142)

  • 21. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
    Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
    Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
    Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
    J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
    Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
    BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma.
    Li KS; Zhu XD; Liu HD; Zhang SZ; Li XL; Xiao N; Liu XF; Xu B; Lei M; Zhang YY; Shi WK; Cao MQ; Xu YF; Tang ZY; Sun HC
    Cell Death Dis; 2020 May; 11(5):335. PubMed ID: 32382041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ICT1 predicts a poor survival and correlated with cell proliferation in diffuse large B-cell lymphoma.
    Xie W; Wu M; Fu T; Li X; Wang Z; Hu Y; Zhu L; Zhang G
    Gene; 2017 Sep; 627():255-262. PubMed ID: 28629825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticancer effect of quinacrine on diffuse large B‑cell lymphoma via inhibition of MSI2‑NUMB signaling pathway.
    Yang S; Sheng L; Xu K; Wang Y; Zhu H; Zhang P; Mu Q; Ouyang G
    Mol Med Rep; 2018 Jan; 17(1):522-530. PubMed ID: 29115587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR‑29b suppresses proliferation and induces apoptosis of hepatocellular carcinoma ascites H22 cells via regulating TGF‑β1 and p53 signaling pathway.
    Liu YL; Yang WH; Chen BY; Nie J; Su ZR; Zheng JN; Gong ST; Chen JN; Jiang D; Li Y
    Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34184070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway.
    Lu K; Li B; Zhang H; Xu Z; Song D; Gao L; Sun H; Li L; Wang Y; Feng Q; Chen G; Hu L; Wei R; Xie Y; Yu D; Wu X; Zhu W; Shi J
    Signal Transduct Target Ther; 2020 Apr; 5(1):31. PubMed ID: 32296013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.
    Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y
    Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SENP1 knockdown potentiates the apoptosis, cell cycle arrest, and reduces cisplatin resistance of diffuse large B cell lymphoma cells via inducing ferroptosis.
    Dong J; Zheng X
    Biochem Cell Biol; 2024 Aug; 102(4):319-330. PubMed ID: 38708853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA PVT1 facilitates DLBCL development via miR-34b-5p/Foxp1 pathway.
    Tao S; Chen Y; Hu M; Xu L; Fu CB; Hao XB
    Mol Cell Biochem; 2022 Mar; 477(3):951-963. PubMed ID: 35098439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CircRNA_OTUD7A upregulates FOXP1 expression to facilitate the progression of diffuse large B-cell lymphoma via acting as a sponge of miR-431-5p.
    Liu W; Lei L; Liu X; Ye S
    Genes Genomics; 2021 Jun; 43(6):653-667. PubMed ID: 33830472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.
    Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q
    Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p/CBX3 axis in diffuse large B-cell lymphoma.
    Huang Y; Lin Y; Song X; Wu D
    Carcinogenesis; 2021 May; 42(5):733-741. PubMed ID: 33657224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Andrographolide Induces G2/M Cell Cycle Arrest and Apoptosis in Human Glioblastoma DBTRG-05MG Cell Line via ERK1/2 /c-Myc/p53 Signaling Pathway.
    Othman NS; Mohd Azman DK
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
    Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma.
    Ding T; Hao J
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-377-3p promotes cell proliferation and inhibits cell cycle arrest and cell apoptosis in hepatocellular carcinoma by affecting EGR1-mediated p53 activation.
    Li W; Li K; Wang Z; Fa Z
    Pathol Res Pract; 2022 Jun; 234():153855. PubMed ID: 35461040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma.
    Yousefi Z; Sharifzadeh S; Zare F; Eskandari N
    Mol Biol Rep; 2023 Feb; 50(2):1133-1145. PubMed ID: 36409389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.